Table 2.
Treatment Group | Males CORT AUC (ng/ml x min) |
Females CORT AUC (ng/ml x min) |
---|---|---|
SAL + SAL | 2551 ± 1355a | 7174 ± 1733a |
SAL + PHYSO | 10710 ± 2045c | 12686 ± 3707c |
| ||
SCOP 0.3 + PHYSO | 12889 ± 1696ac | 22602 ± 1773acd |
SCOP 0.3 + SAL | 10336 ± 1739ac | 19757 ± 2407acd |
| ||
PIREN 10 + PHYSO | 10153 ± 1359ac | 14678 ± 3076ac |
PIREN 30 + PHYSO | 16545 ± 1451acd | 22364 ± 3749acd |
PIREN 70 + PHYSO | 23502 ± 2421acd | 28444 ± 2682acd |
PIREN 10 + SAL | 6878 ± 1270a | 15760 ± 3663ac |
| ||
METHO 0.3 + PHYSO | 9908 ± 2272c | 11132 ± 4064 |
METHO 1 + PHYSO | 5898 ± 1087 | 5031 ± 2130d |
METHO 3 + PHYSO | 13246 ± 1754ac | 20975 ± 2663acd |
METHO 1 + SAL | 411 ± 1744ad | 11472 ± 3424a |
AUCs presented as mean ± SEM.
sex difference at indicated dose (p < 0.05);
vs. SAL + SAL (p < 0.05);
vs. SAL + PHYSO (p < 0.05).